menu
    • menu

    Company profile for Arcutis Biotherapeutics

    NEW Drugs in Dev: 6
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Arcutis Biotherapeutics is a privately held clinical-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology. Our strategy is to exploit recent innovations in inflammation and immunology to bring the best molecules to bear against validated physiologic targets known to treat dermatological diseases and ...
    Arcutis Biotherapeutics is a privately held clinical-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology. Our strategy is to exploit recent innovations in inflammation and immunology to bring the best molecules to bear against validated physiologic targets known to treat dermatological diseases and disorders. Our management team has extensive expertise in the development and commercialization of medical dermatology products.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Arcutis BiotherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2945 Townsgate Road, Suite 110 Westlake Village CA 91361
    Telephone
    Telephone
    805-418-5006
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.arcutis.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/arcutis-inc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Arcutis Biotherapeutics Issues Inducement Grants Under Nasdaq
    Arcutis Biotherapeutics Issues Inducement Grants Under Nasdaq

    08 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/08/3291317/0/en/arcutis-biotherapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html

    GLOBENEWSWIRE
    08 May 2026
    Share Share
    Arcutis Unveils Q1 2026 Financials And Business Update
    Arcutis Unveils Q1 2026 Financials And Business Update

    06 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/06/3289285/0/en/arcutis-announces-first-quarter-2026-financial-results-and-provides-business-update.html

    GLOBENEWSWIRE
    06 May 2026
    Share Share
    Arcutis Submits sNDA for ZORYVE in Infants with Atopic Dermatitis
    Arcutis Submits sNDA for ZORYVE in Infants with Atopic Dermatitis

    27 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7212866

    FIRSTWORD PHARMA
    27 Apr 2026
    Share Share
    Arcutis Submits Supplemental NDA to FDA for ZORYVE Cream 0.05%
    Arcutis Submits Supplemental NDA to FDA for ZORYVE Cream 0.05%

    27 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/27/3281570/0/en/arcutis-submits-supplemental-new-drug-application-to-the-fda-for-zoryve-roflumilast-cream-0-05-to-expand-indication-for-treatment-of-atopic-dermatitis-to-infants-down-to-3-months.html

    GLOBENEWSWIRE
    27 Apr 2026
    Share Share
    Arcutis To Present Q1 2026 Financial Results, Host Conference
    Arcutis To Present Q1 2026 Financial Results, Host Conference

    15 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/15/3274854/0/en/Arcutis-to-Report-First-Quarter-2026-Financial-Results-and-Host-Conference-Call-on-May-6-2026.html

    GLOBENEWSWIRE
    15 Apr 2026
    Share Share
    Arcutis to Present at 25th Annual Needham Healthcare Conference
    Arcutis to Present at 25th Annual Needham Healthcare Conference

    31 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/31/3265990/0/en/Arcutis-Management-to-Present-at-the-25th-Annual-Needham-Virtual-Healthcare-Conference.html

    GLOBENEWSWIRE
    31 Mar 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search